Atlas Trials

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Clinical trial NCT04709380 · TERMINATED

Trial details

NCT number
NCT04709380
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
RadiotherapyToripalimabSorafenibAdvanced Hepatocellular Carcinoma
Start date
2021-03-02
Primary completion
2024-12-27
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.